IN192748B - - Google Patents
Info
- Publication number
- IN192748B IN192748B IN778DE2000A IN192748B IN 192748 B IN192748 B IN 192748B IN 778DE2000 A IN778DE2000 A IN 778DE2000A IN 192748 B IN192748 B IN 192748B
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN778DE2000 IN192748B (bg) | 2000-08-29 | 2000-08-29 | |
PCT/IB2001/001564 WO2002017885A2 (en) | 2000-08-29 | 2001-08-29 | Controlled release formulation of erythromycin or a derivative thereof |
AU2001284324A AU2001284324A1 (en) | 2000-08-29 | 2001-08-29 | Controlled release formulation of erythromycin or a derivative thereof |
EP01963298A EP1315478A2 (en) | 2000-08-29 | 2001-08-29 | Controlled release formulation of erythromycin or a derivative thereof |
US09/941,970 US20020081332A1 (en) | 2000-08-29 | 2001-08-29 | Controlled release formulation of erythromycin or a derivative thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN778DE2000 IN192748B (bg) | 2000-08-29 | 2000-08-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN192748B true IN192748B (bg) | 2004-05-15 |
Family
ID=11097084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN778DE2000 IN192748B (bg) | 2000-08-29 | 2000-08-29 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20020081332A1 (bg) |
EP (1) | EP1315478A2 (bg) |
AU (1) | AU2001284324A1 (bg) |
IN (1) | IN192748B (bg) |
WO (1) | WO2002017885A2 (bg) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
PL366021A1 (en) * | 2000-02-29 | 2005-01-24 | Teva Pharmaceutical Industries Ltd. | Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same |
KR20030011797A (ko) * | 2000-03-28 | 2003-02-11 | 바이오케미 게젤샤프트 엠베하 | 맛이 차폐된 과립형 입자 |
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
US6673369B2 (en) | 2001-08-29 | 2004-01-06 | Ranbaxy Laboratories Limited | Controlled release formulation |
BR0214314A (pt) * | 2001-11-21 | 2004-11-09 | E Z Em Inc | Formulações para uso em procedimentos médicos ou de diagnóstico |
CA2481269A1 (en) * | 2002-04-03 | 2003-10-09 | Ranbaxy Laboratories Limited | Taste masked compositions of erythromycin a and derivatives thereof |
CN1652753A (zh) * | 2002-04-03 | 2005-08-10 | 兰贝克赛实验室有限公司 | 具有改进的生物利用度的克拉霉素制剂 |
US7063862B2 (en) * | 2003-06-03 | 2006-06-20 | Biokey, Inc. | Pharmaceutical composition and method for treating |
WO2005004919A2 (en) * | 2003-07-02 | 2005-01-20 | Eurand, Inc. | Extended release systems for macrolide antibiotics |
US8425936B2 (en) | 2003-07-21 | 2013-04-23 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
US8313776B2 (en) | 2003-07-21 | 2012-11-20 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
EP1646367A4 (en) * | 2003-07-21 | 2011-06-15 | Nesher Solutions Ltd | ORAL DOSAGE FORMS WITH CONTROLLED RELEASE ON GELLAN RUBBER BASE A NEW PLATFORM TECHNOLOGY FOR MAGNETIC RETENTION |
AU2004258953B2 (en) | 2003-07-21 | 2011-02-10 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
JP2007502296A (ja) | 2003-08-11 | 2007-02-08 | アドバンシス ファーマスーティカル コーポレイション | ロバストペレット |
WO2005016278A2 (en) | 2003-08-12 | 2005-02-24 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
WO2005023184A2 (en) | 2003-08-29 | 2005-03-17 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
US8460710B2 (en) | 2003-09-15 | 2013-06-11 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
US8168228B2 (en) | 2003-10-17 | 2012-05-01 | Sandoz Ag | Antibiotic clarithromycin micropellet compositions |
US7943585B2 (en) | 2003-12-22 | 2011-05-17 | Sandoz, Inc. | Extended release antibiotic composition |
US20050260263A1 (en) * | 2004-05-18 | 2005-11-24 | Panion & Bf Biotech Inc. | Sustained release formulation for sparingly soluble main drugs |
CA2572292A1 (en) | 2004-07-02 | 2006-02-09 | Advancis Pharmaceutical Corporation | Tablet for pulsed delivery |
US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8299052B2 (en) | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
WO2011125075A2 (en) * | 2010-04-08 | 2011-10-13 | Fdc Limited | A novel gastroretentive delivery of macrolide |
EP2671571A1 (en) * | 2012-06-05 | 2013-12-11 | Sanovel Ilac Sanayi ve Ticaret A.S. | Controlled-release formulations of clarithromycin |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4076804A (en) * | 1975-07-18 | 1978-02-28 | Abbott Laboratories | Erythromycin therapy |
GB1577196A (en) * | 1977-06-03 | 1980-10-22 | Ile De France | Compositions containing erythromycin and metoclopramide |
US5009897A (en) * | 1988-06-24 | 1991-04-23 | Abbott Laboratories | Pharmaceutical granules and tablets made therefrom |
US5705190A (en) * | 1995-12-19 | 1998-01-06 | Abbott Laboratories | Controlled release formulation for poorly soluble basic drugs |
US6010718A (en) * | 1997-04-11 | 2000-01-04 | Abbott Laboratories | Extended release formulations of erythromycin derivatives |
AU758324B2 (en) * | 1998-09-14 | 2003-03-20 | Ranbaxy Laboratories Limited | Orally administered controlled drug delivery system providing temporal and spatial control |
SI20150A (sl) * | 1999-02-19 | 2000-08-31 | Lek, Tovarna Farmacevtskih In | Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina |
-
2000
- 2000-08-29 IN IN778DE2000 patent/IN192748B/en unknown
-
2001
- 2001-08-29 US US09/941,970 patent/US20020081332A1/en not_active Abandoned
- 2001-08-29 EP EP01963298A patent/EP1315478A2/en not_active Withdrawn
- 2001-08-29 WO PCT/IB2001/001564 patent/WO2002017885A2/en not_active Application Discontinuation
- 2001-08-29 AU AU2001284324A patent/AU2001284324A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002017885A2 (en) | 2002-03-07 |
AU2001284324A1 (en) | 2002-03-13 |
WO2002017885A3 (en) | 2002-09-06 |
US20020081332A1 (en) | 2002-06-27 |
EP1315478A2 (en) | 2003-06-04 |